Company Overview - Polyrizon Ltd. is a development stage biotech company focused on innovative intranasal hydrogels [3] - The company specializes in medical device hydrogels delivered as nasal sprays, creating a barrier against viruses and allergens [3] - Polyrizon's proprietary technology, Capture and Contain (C&C), aims to function as a "biological mask" in the nasal cavity [3] Recent Developments - Polyrizon has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. SEC [1] - The report is accessible on the SEC's website and Polyrizon's Investor Relations website [2] Technology and Research - The company is developing its C&C hydrogel technology to enhance bioadhesion and retention for drug delivery [3] - An additional technology, Trap and Target (T&T), is in pre-clinical development for nasal delivery of active pharmaceutical ingredients [3]
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024